Medefil Incorporated – FDA 483, Apr 21, 2025
Medefil, Inc., a sterile drug manufacturer in Glendale Heights, IL, was cited for significant deficiencies during an FDA inspection. The observations primarily concern inadequate investigations into unknown impurities in drug products, insufficient controls over computerized systems for production data, and failures in equipment cleaning and laboratory procedure adherence. These issues indicate a lack of robust quality control and sanitation practices that could impact product safety and purity.
ID · 3c3e9aa6-79c7-40ce-9e78-a0f762e3d3ce
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.